iiCON Launches Next Phase to Accelerate Pioneering Infection R&D Supported by £6 million UKRI Grant
The Infection Innovation Consortium: iiCON has launched the second phase of…
Infex CSO invited to speak at GARDP REVIVE Webinar
On 27th June, Dr Victoria Savage, Chief Scientific Officer for Infex…
